SITC 2019 General Registration Now Open!Attend the leading destination for scientific exchange, education & networking in the cancer immunotherapy field.
JUST RELEASED: SITC's Guide to Managing Immunotherapy Toxicity A new handbook from SITC for clinicians providing thorough coverage of the toxicity and management of adverse events for immune checkpoint inhibitors.Purchase Today
Enduring Materials Are Now Open Access for All SITC Members.
Submit an abstract for SITC 2019 Submit a regular abstract, Young Investigator Award abstract and/or late-breaking abstract application by 5 p.m. PDT on Aug. 1, 2019.
ASCO-SITC Pre-Annual Meeting SeminarAttend this multi-disciplinary seminar covering new immunotherapy research & treatments options in clinical settings. May 30 - 31, 2019 | Chicago, IL
REGISTER TODAYJoin SITC for two back-to-back immuno-oncology workshops.Sept. 4 - 6, 2019 | Houston, Texas
Join Alessandra Cesano, MD, PhD, and the thousands of other cancer immunotherapy professionals who proudly call themselves SITC members.
Inspire the Next Generation of Cancer Immunotherapy Leaders
Advance the science of cancer immunotherapy and help young investigators tackle hurdles facing the field with a gift to the SITC Forward Fund.
SITC Speakers at ICVI SymposiumJoin SITC and the Institute for Cancer Vaccines and Immunotherapy for the 4th International Symposium on Immunotherapy May 24-25, 2019 in London.
Explore resources and educational opportunities for cancer patients and those who advocate for them.
Track the latest advancements and educational opportunities in cancer immunotherapy and immunology.
Advance science, submit your manuscript and monitor the global progress of cancer immunotherapy research.
Thank you Fabiana! Suggestions noted. For starters, if you have not yet done that, please apply to the WIN database (Women in Cancer Immunotherapy network) under the volunteer options. WIN is looking to create a database that can be used to better identify ...
Hi Priscilla, it is a fact that women face additional challenges at advancing their careers compared to their male peers. I suggest we create more spots to increase female colleagues visibility at conferences (chairing sessions for instance) and perhaps ...
Hello ladies I am excited to share that I am now a member of the SITC Early Career Scientist Committee! I would love to hear from you regarding any ideas/suggestions on how this committee can help women improve their careers in immunology. Priscila ------------------------------ ...
Donate today to support early career scientists who are emerging leaders seeking to advance research in the cancer immunotherapy field.
An open access, peer-reviewed journal, the Journal for ImmunoTherapy of Cancer (JITC) is the global voice of the society, producing original research articles, literature reviews and more on tumor immunology and cancer immunotherapy.
It is the mission of the Society for Immunotherapy of Cancer (SITC) to improve cancer patient outcomes by advancing the science, development and application of cancer immunology and immunotherapy through our core values of interaction/integration, innovation, translation and leadership in the field. SITC aims to make cancer immunotherapy a standard of care and the word “cure” a reality for cancer patients everywhere.
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: firstname.lastname@example.org